CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
3.020
+0.080 (2.72%)
At close: Mar 9, 2026, 4:00 PM EDT
3.040
+0.020 (0.66%)
After-hours: Mar 9, 2026, 7:02 PM EDT
CNS Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2 | 7 | 7 | 3 | 20 | 40 | |
| Market Cap Growth | -66.68% | 4.40% | 109.26% | -83.83% | -51.07% | -37.41% | |
| Enterprise Value | -8 | -0 | 6 | -4 | 11 | 39 | |
| Last Close Price | 3.02 | 72.24 | 38100.04 | 72000.07 | 632166.32 | 1602016.02 | |
| PB Ratio | 0.18 | 1.12 | -1.50 | 0.39 | 3.18 | 2.87 | |
| P/TBV Ratio | 0.19 | 1.12 | - | 0.39 | 3.18 | 2.87 | |
| Debt / Equity Ratio | 0.00 | 0.05 | -0.07 | 0.05 | 0.06 | 0.03 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | 0.06 | -1.19 | -0.75 | -0.97 | |
| Net Debt / EBITDA Ratio | 0.75 | 0.41 | 0.01 | 0.63 | 0.32 | 1.44 | |
| Net Debt / FCF Ratio | 0.61 | 0.36 | 0.02 | 0.91 | 0.34 | 1.85 | |
| Quick Ratio | 5.04 | 2.91 | 0.09 | 2.04 | 1.93 | 7.37 | |
| Current Ratio | 5.82 | 3.43 | 0.26 | 2.55 | 2.88 | 8.13 | |
| Return on Equity (ROE) | -197.11% | -1703.39% | -1018.78% | -213.68% | -144.15% | -87.78% | |
| Return on Assets (ROA) | -85.59% | -179.08% | -159.83% | -87.50% | -73.58% | -49.73% | |
| Return on Capital Employed (ROCE) | -133.20% | -241.30% | 425.60% | -187.70% | -235.00% | -67.80% | |
| Earnings Yield | -697.77% | -214.67% | -284.36% | -482.14% | -73.97% | -23.61% | |
| FCF Yield | -866.63% | -247.31% | -213.35% | -333.40% | -69.11% | -18.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.